Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle

Clinical trial NCT06010537 · COMPLETED

Trial details

NCT number: NCT06010537
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Magnetic Resonance Imaging

Start date: 2021-04-28
Primary completion: 2021-04-30
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.